Privacy Policy

We hate spam just as much as you do

Personal Information

As part of providing the service we collect some personal information, like an email, name, and IP address. We use the information for the purpose for which it is provided and to facilitate the provision of our service. We will use the information, like an IP address, to validate the account and use automated spam, security detection, and similar services to maintain the integrity of our site and avoid misuse of the subscription.

For users that register on our websites, the personal information is stored in their user profile. A user can see, edit, or delete their personal information at any time (except the username). Website administrators can also see and edit that information. We secure our website, but a data breach is possible.

Sharing Information

Any personal information you provide, like an email, is not shared with marketing vendors, other newsletter service providers, or unrelated parties, even after you stop using the service.

Payment Information

We do not collect payment information. We use third party service providers, like Paypal, Stripe, and Google, to process payments. Thus, no payment information, like a credit card number, is saved on our website.

Cookies

When you visit our login page, we may set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser. When you log in, we will give you an option to select "Remember Me." This is for your convenience. If you select the option, a cookie will be saved in your browser to assist you with login the next time. 

Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‘Graycell’ and/or ‘we,’ is a publisher of financial information, such as the Prudent Small Cap, Prudent Biotech, and Prudent Healthcare newsletters. We are not a Registered Investment Advisor (RIA). Historical performance figures provided are hypothetical, unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period. Hypothetical or simulated performance results have limitations, and unlike an actual performance record, simulated results do not represent actual trading and consequently do not involve the financial risk of actual trading. The performance results obtained are intended for illustrative purposes only. No representation is being made that any account will or is likely to achieve profit or losses similar to those shown. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, the biotech industry and small caps are characterized by much higher risk and volatility than the general stock market. Information contained herein is general and does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your investment decisions. Use of the information herein is at one's own risk. We are simply sharing the results of our model. Nothing should be construed as a recommendation or an offer to buy or sell any securities, and we are not liable nor do we assume any liability or responsibility for losses incurred as a result of any information provided or not provided or not made available on time, herein or on our website or using any other medium. We cannot guarantee the accuracy and completeness of any information furnished by us. We may or may not have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or can be licensed and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their due diligence with any potential investment and consider obtaining professional advice before making an investment decision.

© Graycell Advisors. All rights reserved. Any act of copying, reproducing, or distributing this newsletter whether wholly or in part, for any purpose without the written permission of Graycell Advisors is strictly prohibited and shall be deemed to be copyright infringement.

© 2003-2024 Graycell Advisors. All Rights Reserved. USA


Page Created with OptimizePress